Skip to main content

Advertisement

Fig. 4 | Cell & Bioscience

Fig. 4

From: Biologically active, high levels of interleukin-22 inhibit hepatic gluconeogenesis but do not affect obesity and its metabolic consequences

Fig. 4

Chronic administration of rmIL-22 protein does not affect body weight and insulin resistance in HFD-fed mice. Mice were fed a HFD for 5 months and then injected with rmIL-22 (20 ng/g body weight, i.p. injection, twice a week) or saline for an additional four weeks. a Body weights were measured. b Fasting blood glucose levels. Values represent the mean ± SEM (n = 8)

Back to article page